Tag Visualization: Top 50 related tags by occurrence
The effect of immunosuppressive therapies on the endothelial host response in critically ill ...
Added to Collection on: 2024-04-20 16:50:43
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Induction and Transplant Outcomes Improve With Quadruplet NDMM Regimen
Added to Collection on: 2024-05-24 21:18:47
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Daratumumab Treatment Advancements in Newly Diagnosed Multiple Myeloma
Added to Collection on: 2024-06-03 16:07:51
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
COVID-19 and pregnancy: An update - Contemporary OB/GYN
Added to Collection on: 2024-06-04 21:16:08
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
EHA 2024: Monoclonal antibodies continue to dominate multiple myeloma treatments
Added to Collection on: 2024-06-21 22:47:30
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
BENEFIT Trial Results Show Quadruplet Regimen for NDMM TI May Require Weighing ...
Added to Collection on: 2024-06-22 11:23:43
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Belantamab Mafodotin–Based PFS Benefits in Difficult-to-Treat R/R Myeloma Subgroups
Added to Collection on: 2024-07-01 13:06:37
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
FDA Accepts GSK's Biologics License Application of Blenrep for Relapsed or Refractory ...
Added to Collection on: 2024-12-02 19:42:08
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of ...
Added to Collection on: 2025-01-22 08:59:35
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
China's NMPA Approves Isatuximab Plus VRd for Newly Diagnosed, Transplant-Ineligible Myeloma
Added to Collection on: 2025-01-31 22:36:35
Tags for this article:
Click the tags to see associated articles and topics
View Article Details